What Happens to GAVI with America’s Withdrawal?
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
What Happens to GAVI with America’s Withdrawal?
-
ナレーター：
-
著者：
このコンテンツについて
In this episode of A Moment in Health, Dr. Ashish Jha illustrates the economic benefits of health insurance coverage and a new study linking adjuvanted vaccines for shingles and RSV to a lower risk of dementia. Senior Adviser to the Pandemic Center and former Gavi CEO Dr. Seth Berkley joins to discuss the consequences of the recent U.S. withdrawal of funding for Gavi, noting the cost-effectiveness of vaccines and the loss of vaccinations for 75 million children.
Dr. Jha discusses:
- Health insurance as a productive factor — Labour Economics
- Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections — npj Vaccines
About the Guest
Dr. Seth Berkley is a Senior Advisor to the Brown University Pandemic Center and a serial entrepreneur and pioneer in global public health for more than 35 years. From 2011 to 2023, he served as CEO of Gavi, the Vaccine Alliance. During his tenure at Gavi, Berkley led a team that worked toward broadening global immunization access, resulting in more than half of the world’s children being vaccinated annually.
About the HostDr. Ashish K. Jha is the dean of the Brown University School of Public Health.
Music by Katherine Beggs, additional music by Lulu West and Maya Polsky